DAILY RAPID BLOOD-GLUCOSE VARIATIONS MAY CONDITION ANTITHROMBIN III BIOLOGIC ACTIVITY BUT NOT ITS PLASMA-CONCENTRATION IN INSULIN-DEPENDENT DIABETES - A POSSIBLE ROLE FOR LABILE NONENZYMATIC GLYCATION
- 1 February 1987
- journal article
- research article
- Vol. 13 (1) , 16-19
Abstract
The effect of rapid daily variation of glycemia and labile HbA1 on both antithrombin III (ATIII) activity and plasma concentration in ten insulin dependent diabetics has been evaluated. The variations of both plasma glucose and labile HbA1 were inversely correlated to the alterations of ATIII activity (r = -0.71 and r = -0.73, respectively, p < 0.001), while no change in ATIII plasma concentration was present. These data suggest a direct role of glucose in determining rapid alteration of ATIII biologic activity, in vivo, in diabetes, probably mediated by labile non-enzymatic glycation.This publication has 5 references indexed in Scilit:
- Thermal stabilization of antithrombin III by sugars and sugar derivatives and the effects on nonenzymatic glycosylationBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Decreased Antithrombin III Activity in Diabetes May Be Due to Non-Enzymatic Glycosylation – A Preliminary ReportThrombosis and Haemostasis, 1983
- Reduced Fibrinogen Survival in Diabetes MellitusJournal of Clinical Investigation, 1979
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- Human C-peptide immunoreactivity (CPR) in blood and urine ? Evaluation of a radioimmunoassay method and its clinical applicationsDiabetologia, 1976